0
     

Report Added
Report already added
Chronic Obstructive Pulmonary Disorder (COPD) Market - Global Outlook and Forecast 2022-2028

Chronic Obstructive Pulmonary Disorder (COPD) Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Chronic Obstructive Pulmonary Disorder (COPD) in Global, including the following market information:

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Obstructive Pulmonary Disorder (COPD) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Short-Acting Bronchodilators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Obstructive Pulmonary Disorder (COPD) include GSK, Pfizer, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Ario Pharma and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Obstructive Pulmonary Disorder (COPD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Chronic Obstructive Pulmonary Disorder (COPD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment Percentages, by Type, 2021 (%)
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Others
Global Chronic Obstructive Pulmonary Disorder (COPD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Chronic Obstructive Pulmonary Disorder (COPD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chronic Obstructive Pulmonary Disorder (COPD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Obstructive Pulmonary Disorder (COPD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Obstructive Pulmonary Disorder (COPD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Merck
Novartis
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceuticals
Ario Pharma
Roche
Ache
Almirall
Aquinox Pharmaceuticals
Asmacure
Astellas Pharma
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Chronic Obstructive Pulmonary Disorder (COPD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Obstructive Pulmonary Disorder (COPD) Overall Market Size
2.1 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size: 2021 VS 2028
2.2 Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Obstructive Pulmonary Disorder (COPD) Players in Global Market
3.2 Top Global Chronic Obstructive Pulmonary Disorder (COPD) Companies Ranked by Revenue
3.3 Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Companies
3.4 Top 3 and Top 5 Chronic Obstructive Pulmonary Disorder (COPD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Obstructive Pulmonary Disorder (COPD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disorder (COPD) Players in Global Market
3.6.1 List of Global Tier 1 Chronic Obstructive Pulmonary Disorder (COPD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disorder (COPD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size Markets, 2021 & 2028
4.1.2 Short-Acting Bronchodilators
4.1.3 Corticosteroids
4.1.4 Methylxanthines
4.1.5 Long-Acting Bronchodilators
4.1.6 Phosphodiesterase-4 Inhibitors
4.1.7 Others
4.2 By Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue & Forecasts
4.2.1 By Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2022
4.2.2 By Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2023-2028
4.2.3 By Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue & Forecasts
5.2.1 By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2022
5.2.2 By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2023-2028
5.2.3 By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2021 & 2028
6.2 By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue & Forecasts
6.2.1 By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2022
6.2.2 By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2023-2028
6.2.3 By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028
6.3.2 US Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.3.3 Canada Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.3.4 Mexico Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028
6.4.2 Germany Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.3 France Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.4 U.K. Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.5 Italy Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.6 Russia Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.7 Nordic Countries Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.4.8 Benelux Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028
6.5.2 China Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.5.3 Japan Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.5.4 South Korea Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.5.5 Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.5.6 India Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028
6.6.2 Brazil Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.6.3 Argentina Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028
6.7.2 Turkey Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.7.3 Israel Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.7.4 Saudi Arabia Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
6.7.5 UAE Chronic Obstructive Pulmonary Disorder (COPD) Market Size, 2017-2028
7 Players Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.1.4 GSK Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.1.5 GSK Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.2.4 Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.3.4 Merck Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.3.5 Merck Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.4.4 Novartis Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.4.5 Novartis Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.5.4 AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.6.4 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Corporate Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.7.4 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.7.5 Teva Pharmaceuticals Key News
7.8 Ario Pharma
7.8.1 Ario Pharma Corporate Summary
7.8.2 Ario Pharma Business Overview
7.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.8.4 Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.8.5 Ario Pharma Key News
7.9 Roche
7.9.1 Roche Corporate Summary
7.9.2 Roche Business Overview
7.9.3 Roche Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.9.4 Roche Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.9.5 Roche Key News
7.10 Ache
7.10.1 Ache Corporate Summary
7.10.2 Ache Business Overview
7.10.3 Ache Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.10.4 Ache Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.10.5 Ache Key News
7.11 Almirall
7.11.1 Almirall Corporate Summary
7.11.2 Almirall Business Overview
7.11.3 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.11.4 Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.11.5 Almirall Key News
7.12 Aquinox Pharmaceuticals
7.12.1 Aquinox Pharmaceuticals Corporate Summary
7.12.2 Aquinox Pharmaceuticals Business Overview
7.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.12.4 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.12.5 Aquinox Pharmaceuticals Key News
7.13 Asmacure
7.13.1 Asmacure Corporate Summary
7.13.2 Asmacure Business Overview
7.13.3 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.13.4 Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.13.5 Asmacure Key News
7.14 Astellas Pharma
7.14.1 Astellas Pharma Corporate Summary
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Major Product Offerings
7.14.4 Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global Market (2017-2022)
7.14.5 Astellas Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Chronic Obstructive Pulmonary Disorder (COPD) Market Opportunities & Trends in Global Market
Table 2. Chronic Obstructive Pulmonary Disorder (COPD) Market Drivers in Global Market
Table 3. Chronic Obstructive Pulmonary Disorder (COPD) Market Restraints in Global Market
Table 4. Key Players of Chronic Obstructive Pulmonary Disorder (COPD) in Global Market
Table 5. Top Chronic Obstructive Pulmonary Disorder (COPD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Obstructive Pulmonary Disorder (COPD) Product Type
Table 9. List of Global Tier 1 Chronic Obstructive Pulmonary Disorder (COPD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Obstructive Pulmonary Disorder (COPD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Obstructive Pulmonary Disorder (COPD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 32. GSK Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 35. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 38. Merck Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 41. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 44. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 47. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceuticals Corporate Summary
Table 49. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 50. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 51. Ario Pharma Corporate Summary
Table 52. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 53. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 56. Roche Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 57. Ache Corporate Summary
Table 58. Ache Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 59. Ache Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 60. Almirall Corporate Summary
Table 61. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 62. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 63. Aquinox Pharmaceuticals Corporate Summary
Table 64. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 65. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 66. Asmacure Corporate Summary
Table 67. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 68. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)
Table 69. Astellas Pharma Corporate Summary
Table 70. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Product Offerings
Table 71. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Chronic Obstructive Pulmonary Disorder (COPD) Segment by Type in 2021
Figure 2. Chronic Obstructive Pulmonary Disorder (COPD) Segment by Application in 2021
Figure 3. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder (COPD) Revenue in 2021
Figure 8. By Type - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 12. US Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 24. China Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Obstructive Pulmonary Disorder (COPD) Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Obstructive Pulmonary Disorder (COPD) Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ario Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Ache Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Almirall Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Asmacure Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Astellas Pharma Chronic Obstructive Pulmonary Disorder (COPD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Chronic Obstructive Pulmonary Disorder (COPD) Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Bispecific Antibody Market Opportunity, Drug Sales, Price  & Clinical Trials Insight 2028

Global Bispecific Antibody Market Opportunity, Drug Sales, Price & Clinical Trials Insight 2028

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

Europe Digital Therapeutics Market by Application (Diabetes, Obesity, CVD, CNS Disease Respiratory Diseases, Smoking Cessation and Others); By End Use (Patients, Providers, Payers, Employers and Others); By Type (Software and Devices), and Region – Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

AI for Drug Discovery Market By Offering (Software, Services);By Technology (Machine Learning and Other Technologies); By Drug Type (Small Molecule and Large Molecules); By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases and Other Applications); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030

AI for Drug Discovery Market By Offering (Software, Services);By Technology (Machine Learning and Other Technologies); By Drug Type (Small Molecule and Large Molecules); By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases and Other Applications); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centers and Academic & Government Institutes)and Region – Analysis of Market Size, Share & Trends for 2018 – 2020 and Forecasts to 2030

Life Science Analytics Market: Market Segments: By Type (Reporting, Descriptive, Predictive and Prescriptive); By Application (Research and Development, Sales and Marketing, Regulatory Compliance, Supply Chain Analytics and Pharmacovigilance); By Delivery Model (On-demand and On-premises); By End-user (Medical Devices, Pharmaceutical, Biotechnology and Others); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Life Science Analytics Market: Market Segments: By Type (Reporting, Descriptive, Predictive and Prescriptive); By Application (Research and Development, Sales and Marketing, Regulatory Compliance, Supply Chain Analytics and Pharmacovigilance); By Delivery Model (On-demand and On-premises); By End-user (Medical Devices, Pharmaceutical, Biotechnology and Others); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Healthcare IT Integration Market: Market Segments: By Product & Service (Products and Services); By End-User (Hospitals, Laboratories, Clinics, Diagnostic Imaging Centers and Other); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Healthcare IT Integration Market: Market Segments: By Product & Service (Products and Services); By End-User (Hospitals, Laboratories, Clinics, Diagnostic Imaging Centers and Other); and Region – Global Analysis by Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Ambulatory EHR Market: Market Segments: By Delivery Mode (Cloud-based and On-premise); By Application (Practice Management, Patient Management, e-Prescribing, Referral Management, Population Health Management, Decision Support and Health Analytics); By End-User (Hospital-Owned Ambulatory Centers and Independent Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030

Ambulatory EHR Market: Market Segments: By Delivery Mode (Cloud-based and On-premise); By Application (Practice Management, Patient Management, e-Prescribing, Referral Management, Population Health Management, Decision Support and Health Analytics); By End-User (Hospital-Owned Ambulatory Centers and Independent Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030